Adding docetaxel to radiation therapy improved survival outcomes in cisplatin-ineligible patients with locally advanced head and neck squamous cell carcinoma, a phase III randomised trial showed.

Source: RANZCR has provided this submission to Cancer Australia’s consultation as part of the development of the Australian Cancer Plan 2023–2033. There were 52 recommendations made addressing the following topics: cancer screening, technologies and treatments, digital cancer care strategy, national cancer guidelines, patient access, funding and cancer research.

Radiotherapy is one of the main treatment modalities in cancer management, often used in combination with other treatments, such as surgery or chemotherapy. Approximately 40% of cancer cures are attributed to radiotherapy. Read the full report now